Summary
We have studied anti-LAV/HTLV-III antibody prevalence in individuals at high risk for infection, such as intravenous drug addicts, hemophiliacs and homosexual men. Among intravenous drug addicts, LAV/HTLV-III infection was first recognized in 1981 and positive serum reactions for anti-LAV/HTLV-III antibody rose in successive years to 53%. Anti-LAV/HTLV-III antibody prevalence was 13.5% in the group of homosexual men, while in hemophiliacs treated with commercial concentrates it was 37% in 1984 and had increased to 45% in 1985. There was a significant correlation between antibody status and concentrate consumption in these patients. Results of studies of anti-LAV/HTLV-III antibody patterns with the Western blot technique suggest that antibodies against core proteins (mainly p25 and p18) and the envelope protein gp40 are always present in asymptomatic individuals and in patients with the lymphadenopathy syndrome, but usually not inpatients with full-blown AIDS. These last patients have typical positive reactions only against the envelope proteins gp110 and gp40.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aiuti F., Rossi P., Sirianni M. C., Carbonari M., Popovic M., Sarngadharan M. G., Contu L., Moroni M., Romagnani S., Gallo R. C.: IgM and IgG antibodies to human T-lymphotropic retrovirus HTLV-III in patients with lymphadenopathy syndrome and in individuals at risk for AIDS in Italy — Brit. med. J.291, 165, 1985.
Barrè-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vezinet-Brun F., Rouzioux C., Rozenbaum W., Montagnier L.: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) — Science220, 868, 1983.
Broder S., Gallo R. C.: A pathogenic retrovirus (HTLV-III) linked to AIDS — New Engl. J. Med.311, 1292, 1984.
Brun-Vezinet F., Rouzioux C., Barrè-Sinoussi F., Klatzmann D., Saimot A. G., Rozenbaum W., Christol D., Gluckmann J. C., Montagnier L., Chermann J. C.: Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome — Lanceti, 1253, 1984.
Centers for Disease Control: Update on acquired immune deficiency syndrome (AIDS). United States — Morbid. Mortal. wkly Rep.31, 507, 1982.
Centers for Disease Control: Antibodies to a retrovirus etiologically associated with acquired immunodeficiency syndrome (AIDS) in population with increased incidences of the syndrome — Morbid. Mortal. wkly Rep.33, 377, 1984.
Cheingsong-Popov R., Weiss R. A., Dalgleish A., Tedder R. S., Shanson D. C., Jeffries D. J., Forns R. B., Briggs E. M., Weller I. V. D., Mitton S., Adler M. W., Farthing C., Lawrence A. G., Gazzard B. G., Weber J., Harris J. R. W., Pinching A. J., Craske J., Barbara J. A. J.: Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain — Lancetii, 477, 1984.
Gallo R. C., Salahuddin S. Z., Popovic M., Schearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B., White G., Foster P., Markham P. D.: Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS — Science224, 500, 1984.
Klatzmann D., Barrè-Sinoussi F., Nugeyre M. T., Dauguet C., Vilmer E., Griscelli C., Brun-Vezinet F., Rouzioux C., Gluckmann J. C., Chermann J. C., Montagnier L.: Selective tropism of lymphadenopathy virus (LAV) for helper/inducer T-lymphocytes — Science225, 59, 1984.
Lazzarin A., Galli M., Introna M., Negri C., Mantovani A., Mella L., Ferrante P., Parravicini C., Trombini M., Aiuti F., Moroni M., Zanussi C.: Outbreak of persistent, unexplained generalized lymphadenopathy with immunological abnormalities in drug addicts in Milan — Infection12, 372, 1984.
Mannucci P. M., Ammassari M., Gringeri A., Geroldi D., Zanetti A. R.: Anti-LAV and concentrate consumption in Italian hemophiliacs — Thrombos. Haemost.54, 556, 1985.
Montagnier L., Clavel F., Krust B., Chamaret S., Rey F., Barrè-Sinoussi F., Chermann J. C.: Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus — Virology144, 283, 1985.
Popovic M., Sarngadharan M. G., Read E., Gallo R. C.: Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS — Science224, 497, 1984.
Rossi P., Sirianni M. C., Contu L., Moroni M., Romagnani S., Del Giacco S., Galli M., Lazzarin A., Scano G., Scarpati B., Papetti C., Aiuti F.: Antibodies to human T-lymphotropic retrovirus, HTLV-III, in patients with lymphadenopathy syndrome and in individuals at risk for AIDS in Italy — Immunol. clin. sper.4, 295, 1984.
Safai B., Sarngadharan M. G., Groopman J. E., Arnett K., Popovic M., Sliski A., Schupbach J. L., Gallo R. C.: Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immune deficiency syndrome — Lanceti, 1438, 1984.
Sarngadharan M. G., Popovic M., Bruch L., Schupbach J. L., Gallo R. C.: Antibodies reactive with a human T-lymphotropic retrovirus (HTLV-III) in the serum of patients with AIDS — Science224, 506, 1984.
Schupbach J. L., Popovic M., Gilden R. V., Gonda M. A., Sarngadharan M. G., Gallo R. C.: Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS — Science224, 503, 1984.
Towbin H., Staehlin T., Gordon J.: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications — Proc. nat. Acad. Sci. (Wash.)76, 4350, 1979.
Vilmer E., Barrè-Sinoussi F., Rouzioux C., Gazengel C., Vezinet-Brun F., Dauguet C., Fischer A., Manigne P., Chermann J. C., Griscelli C., Montagnier L.: Isolation of a new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS — Lanceti, 753, 1984.
Author information
Authors and Affiliations
Additional information
This work was partially supported by a grant from theConsiglio Nazionale delle Ricerche (CNR), Roma, Italy,Progetto Finalizzato ‘Tecnologie Biomediche e Sanitarie’.
Rights and permissions
About this article
Cite this article
Zanetti, A.R., Ferroni, P., Colombo, M. et al. Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy. La Ricerca in Clin. Lab. 15, 357–364 (1985). https://doi.org/10.1007/BF03029151
Issue Date:
DOI: https://doi.org/10.1007/BF03029151